Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain-Reference-Cited by-同舟云学术

Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain

Published:2014-03-03 Issue:6 Volume:30 Page:1139-1151
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Coluzzi Flaminia¹²,Ruggeri Matteo³

Affiliation:

1. Dept. Medical and Surgical Sciences and Biotechnologies, Sapienza University of RomeItaly

2. SIAARTI Study Group on Acute and Chronic Pain

3. ALTEMS – Postgraduate School of Health Economics and Management, Catholic University of Sacred Heart of Rome Italy

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2014.894501

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Investigating Functional Impairment in Chronic Low Back Pain: A Qualitative Study from the Patients and Specialists’ Perspectives;Journal of Personalized Medicine;2023-06-19

3. Considerations for perioperative opioid analgesic stewardship in Australia: a focus on tapentadol;Pain Management;2023-05

4. Global Cluster Analysis and Network Visualization in Musculoskeletal Pain Management: A Scientometric Mapping;Orthopaedic Surgery;2022-11-21

5. Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study;Scientific Reports;2022-06-16